CLOROX CO /DE/

CLX 10-Q · Q2 2026

CLX Q2 2026 request

Playground key active
Request URL /api/financials?ticker=CLX&year=2026&quarter=2
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q2 2026 Q2 2025 YoY
Revenue 1,673 1,686 -0.8%
Show Business Segments breakouts
Health and Wellness · Operating Segments 643 628 +2.4%
Household · Operating Segments 419 446 -6.1%
International · Operating Segments 294 274 +7.3%
Lifestyle · Operating Segments 321 338 -5.0%
Show Consolidation Items breakouts
Corporate Non Segment -4
Operating Segments 1,677 1,686 -0.5%
Cost of Revenue 951 948 +0.3%
Show Business Segments breakouts
Health and Wellness · Operating Segments 309 301 +2.7%
Household · Operating Segments 296 300 -1.3%
International · Operating Segments 188 175 +7.4%
Lifestyle · Operating Segments 158 168 -6.0%
Gross Profit 722 738 -2.2%
Selling, General & Administrative 262 280 -6.4%
Advertising Expense 190 191 -0.5%
Research & Development 29 31 -6.5%
Interest Expense 25 22 +13.6%
Other Expense Income Net 1 -23 +104.3%
Income Before Taxes 215 237 -9.3%
Income Tax Expense (Benefit) 54 43 +25.6%
Net Income 161 194 -17.0%
Show Equity Components breakouts
Noncontrolling Interest 4 1 +300.0%
Retained Earnings 157 193 -18.7%
Net Income Loss Attributable To Noncontrolling Interest 4 1 +300.0%
Net Income 157 193 -18.7%
EPS (Basic) 1.29 1.55 -16.8%
EPS (Diluted) 1.29 1.54 -16.2%
Wtd Avg Shares (Basic) 121,602 123,766 -1.7%
Wtd Avg Shares (Diluted) 121,915 124,662 -2.2%
Comprehensive Income 163 159 +2.5%
Gain Loss On Investments -3 1 -400.0%
Income Loss From Equity Method Investments -1 -1 0.0%
Show Business Segments breakouts
International · Operating Segments -1 -1 0.0%

Balance Sheet

Balance Sheet
Metric Q2 2026 Q2 2025 YoY
Current Assets
Cash & Cash Equivalents 227
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Money Market Funds 103
Fair Value Inputs Level2 · Bank Time Deposits 20
Receivables Net Current 671 603 +11.3%
Inventory 608
Prepaid Expenses & Other Current Assets 222 147 +51.0%
Total Current Assets 1,728 1,632 +5.9%
Non-Current Assets
Property, Plant & Equipment 1,247 1,242 +0.4%
Operating Lease Right-of-Use Assets 368 362 +1.7%
Goodwill 1,231 1,219 +1.0%
Other Non-Current Assets 483 548 -11.9%
Total Assets 5,613
Show Business Segments breakouts
Health and Wellness · Operating Segments 1,224
Household · Operating Segments 1,079
International · Operating Segments 1,329
Lifestyle · Operating Segments 1,106
Show Consolidation Items breakouts
Corporate Non Segment 875
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 311
Other Assets
Trademarks Net 502 501 +0.2%
Other Intangible Assets Net 54 73 -26.0%
Current Liabilities
Commercial Paper 307
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 307
Operating Lease Liability Current 83 81 +2.5%
Accounts Payable And Accrued Liabilities Current 1,957 1,460 +34.0%
Total Current Liabilities 2,347 1,730 +35.7%
Non-Current Liabilities
Long-Term Debt 2,486 2,483 +0.1%
Operating Lease Liabilities 341 339 +0.6%
Other Non-Current Liabilities 385 882 -56.3%
Deferred Tax Liabilities 19 22 -13.6%
Total Liabilities 5,578
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 2,793
Long-Term Debt (Q)
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 2,486
Stockholders' Equity
Common Stock 131 131 0.0%
Additional Paid In Capital Common Stock 1,304 1,287 +1.3%
Retained Earnings 190 68 +179.4%
Treasury Stock Common Value -1,591
Accumulated Other Comprehensive Income -159 -181 +12.2%
Total Stockholders' Equity -125
Minority Interest 160 162 -1.2%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 35 121 -71.1%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -2 -2 0.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent 69 80 -13.8%
Accumulated Other Comprehensive Income -159 -181 +12.2%
Accumulated Translation Adjustment -226 -259 +12.7%
Additional Paid In Capital 1,304 1,287 +1.3%
Common Stock 131 131 0.0%
Noncontrolling Interest 160 162 -1.2%
Retained Earnings 190 68 +179.4%
Treasury Stock Common -1,591 -1,346 -18.2%
Total Liabilities & Equity 5,613 5,577 +0.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2026 YTD Q2 2025 YoY
Operating Activities
Depreciation & Amortization 111 107 +3.7%
Show Business Segments breakouts
Health and Wellness · Operating Segments 29 28 +3.6%
Household · Operating Segments 41 38 +7.9%
International · Operating Segments 21 21 0.0%
Lifestyle · Operating Segments 14 11 +27.3%
Show Consolidation Items breakouts
Corporate Non Segment 6 9 -33.3%
Stock-Based Compensation 34 40 -15.0%
Show Business Segments breakouts
Health and Wellness · Operating Segments 8 8 0.0%
Household · Operating Segments 6 6 0.0%
International · Operating Segments 3 3 0.0%
Lifestyle · Operating Segments 4 4 0.0%
Show Consolidation Items breakouts
Corporate Non Segment 13 19 -31.6%
Deferred Income Taxes 92 -19 +584.2%
Other Non-Cash Items -16 5 -420.0%
Increase Decrease In Receivables 156 64 +143.8%
Change in Inventory -83 -12 -591.7%
Change in Prepaid & Other Assets -30 -39 +23.1%
Increase Decrease In Accounts Payable And Accrued Liabilities -6 -138 +95.7%
Operating Lease Right Of Use Asset And Liability Net -4
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable -93 -16 -481.2%
Net Cash from Operations 404 401 +0.7%
Investing Activities
Capital Expenditures -78 -92 +15.2%
Other Investing Activities 1 -1 +200.0%
Net Cash from Investing -77 35 -320.0%
Financing Activities
Proceeds From Repayments Of Short Term Debt 303 184 +64.7%
Share Repurchases -256 -257 +0.4%
Payments Of Dividends Common Stock -302 -302 0.0%
Issuance Of Common Stock For Employee Stock Plans And Other -14 29 -148.3%
Net Cash from Financing -269 -346 +22.3%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1 -3 +133.3%
Net Change in Cash 59 87 -32.2%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 229 294 -22.1%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key